The Allstate Co. (NYSE:ALL) Shares Acquired by Intech Investment Management LLC

Intech Investment Management LLC increased its position in The Allstate Co. (NYSE:ALL - Free Report) by 6.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 147,466 shares of the insurance provider's stock after acquiring an additional 8,412 shares during the period. Intech Investment Management LLC owned approximately 0.06% of Allstate worth $27,967,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. SPC Financial Inc. increased its holdings in Allstate by 3.6% in the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider's stock valued at $297,000 after buying an additional 54 shares during the period. Lake Street Advisors Group LLC increased its holdings in Allstate by 1.8% in the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider's stock valued at $596,000 after buying an additional 54 shares during the period. Abacus Planning Group Inc. increased its holdings in Allstate by 2.4% in the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider's stock valued at $458,000 after buying an additional 56 shares during the period. Chicago Partners Investment Group LLC increased its holdings in Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider's stock valued at $893,000 after buying an additional 59 shares during the period. Finally, Carmichael Hill & Associates Inc. increased its holdings in Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider's stock valued at $87,000 after buying an additional 60 shares during the period. Institutional investors and hedge funds own 76.47% of the company's stock.

Insider Activity

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company's stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.80% of the stock is currently owned by company insiders.

Allstate Stock Performance

Allstate stock opened at $197.29 on Thursday. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 1 year low of $134.17 and a 1 year high of $201.00. The company has a market cap of $52.24 billion, a PE ratio of 12.78, a PEG ratio of 1.76 and a beta of 0.48. The company's 50-day moving average is $190.76 and its two-hundred day moving average is $177.36.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. Allstate's revenue was up 14.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.81 EPS. Equities analysts anticipate that The Allstate Co. will post 16.01 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be paid a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. Allstate's dividend payout ratio (DPR) is presently 23.83%.

Analyst Ratings Changes

ALL has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a research note on Thursday, October 10th. Barclays boosted their target price on shares of Allstate from $175.00 to $187.00 and gave the company an "underweight" rating in a research note on Thursday, October 31st. The Goldman Sachs Group boosted their target price on shares of Allstate from $209.00 to $230.00 and gave the company a "buy" rating in a research note on Friday, November 15th. Jefferies Financial Group boosted their target price on shares of Allstate from $231.00 to $267.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Finally, BMO Capital Markets boosted their target price on shares of Allstate from $205.00 to $214.00 and gave the company an "outperform" rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Allstate has a consensus rating of "Moderate Buy" and an average price target of $214.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.